Ondansetron and Wegovy: what you need to know before combining them

Ondansetron is a 5-HT3 receptor antagonist commonly used for chemotherapy-related and post-operative nausea; it is not licensed as a routine anti-emetic for GLP-1 side effects.
Both ondansetron and semaglutide can independently affect cardiac conduction (QT interval prolongation); combining them may amplify that risk.
Wegovy-related nausea typically peaks in the first few weeks after a dose increase and settles for most people without extra medication.
A prescriber must review your full medicine list and cardiac history before ondansetron is considered alongside Wegovy.

If nausea from Wegovy has prompted a conversation about ondansetron, you are far from alone. Ondansetron is a prescription anti-emetic sometimes considered to manage severe GI symptoms during semaglutide treatment, but the combination raises a cardiac safety question your prescriber needs to weigh carefully before you take both. Wegovy (semaglutide) is a prescription-only medicine; any decision to add ondansetron to your regimen must go through a clinician, not a pharmacy counter. The NHS medicines page for semaglutide covers the full side-effect picture and is a useful first read.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

The clinical detail: QT prolongation, timing and what your prescriber will assess

Why does ondansetron come up during Wegovy treatment?

Nausea is the side effect people mention most when they start semaglutide or move up to a higher dose. For the majority it is mild, comes and goes in the days after an injection, and is manageable with smaller meals, slower eating, and keeping well hydrated. A minority find it significant enough to consider medication to take the edge off.

Ondansetron is one of the drugs that occasionally gets raised in this context. It works by blocking 5-HT3 receptors in the gut and brain, which interrupts the nausea signal. It is effective, and its reputation from oncology settings has made it something people ask about. That reputation is deserved in its licensed uses. The question is whether it is the right tool for GLP-1-related nausea specifically, and the answer depends partly on how semaglutide behaves in the body. You can read more about semaglutide's mechanism on our semaglutide overview page.

Worth knowing: if you want a broader picture of how Mounjaro and Wegovy compare as treatment options, that context can help you understand why dose titration schedules differ between medicines and why nausea patterns vary. Wegovy nausea usually peaks at the 0.5mg and 1.0mg steps for most patients and then eases. If you are still in the early weeks at a new dose, your prescriber may suggest waiting a short time before reaching for a second medicine. That is not a reason to suffer in silence, though; contact your clinical team if symptoms are stopping you eating, drinking, or functioning day to day.

What is the QT prolongation concern with this combination?

The clearest clinical reason to pause before combining these two medicines is their shared potential to prolong the QT interval, the portion of the heart's electrical cycle measured on an ECG. A prolonged QT interval is generally harmless in isolation, but in some people, particularly at higher doses or when combined with other QT-prolonging medicines, it can tip into an abnormal rhythm called Torsades de Pointes. That is rare but serious.

Ondansetron carries a well-established QT-prolongation warning; the risk is dose-related and highest with the IV form, but it is present with oral doses too. Semaglutide's QT signal is less prominent in its class labelling, but GLP-1 receptor agonists as a group have shown cardiac conduction effects in some trial and post-marketing data. Stacking two medicines that share this mechanism is something a prescriber needs to look at in the context of your personal cardiac history, your current dose of each, and your full medicine list.

The Wegovy SmPC on the eMC lists drug interactions and cardiac precautions in full. Reading that alongside your prescriber's guidance, rather than instead of it, is the sensible approach. If you are already taking ondansetron for another reason and have been prescribed Wegovy, tell your prescriber before your first dose.

Are there safer ways to manage Wegovy nausea first?

Most prescribers will exhaust non-pharmacological options before reaching for a second prescription. The practical list is short but genuinely effective for many people: eat smaller portions, slow right down between bites, avoid fatty or very spicy food in the days around your injection, and stay ahead of dehydration. Injecting in the evening means peak nausea hits while you sleep for many patients.

If simple measures are not enough, some prescribers consider antiemetics with a lower cardiac interaction profile before turning to ondansetron. Metoclopramide or prochlorperazine are sometimes used, though each carries its own cautions. The interaction picture for other medicines alongside semaglutide can be complicated; our page on metronidazole and semaglutide shows how that kind of assessment works in practice.

One quick habit worth building: before you start any new medicine while on Wegovy, including over-the-counter options, check it against a pharmacist or your prescriber. It takes under a minute to ask at a pharmacy counter, and that one check can catch interactions that are not obvious from a packet label. Nutritional considerations matter too; persistent nausea can affect what you eat, and our page on B12 and Wegovy covers one nutrient gap that is easy to overlook.

When should you get medical help?

Contact a doctor or call 111 the same day if nausea is severe enough to prevent fluids going down, if you are vomiting repeatedly, or if you feel dizzy, light-headed or notice your heart beating irregularly. Severe, persistent stomach pain that extends towards the back is a separate concern: it can signal pancreatitis, which requires urgent assessment. The MHRA Yellow Card scheme lets you report suspected side effects from Wegovy, including anything unexpected that happens when you are also taking another medicine.

If you have questions about how your specific medicines interact, or you are considering starting Wegovy for the first time and want your medicine list reviewed, our prescribers work through this at the consultation stage. You can also find context on what treatment costs privately on our Wegovy prices page. The right starting point is always a conversation with a clinician who can see the full picture.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions